NasdaqGS:MEDPLife Sciences
How Investors Are Reacting To Medpace Holdings (MEDP) Fraud Suits Over Backlog And Book-to-Bill Disclosures
In early 2026, Medpace Holdings became the subject of multiple securities fraud class action lawsuits alleging misleading disclosures about backlog cancellations, book-to-bill ratios, and business prospects, coinciding with the announced resignation of its President amid related investigations.
The core allegation is that Medpace’s prior commentary on “well behaved” cancellations and diversified demand conflicted with later fourth-quarter results showing weaker bookings and elevated...